Is It Normal to Have Candida in a Pap Smear?

Finding Candida on a Pap smear is common and, in most cases, completely normal. Candida species are part of the natural vaginal microflora in roughly 20 to 30 percent of healthy women, sitting quietly on mucosal surfaces without causing any symptoms.¹ A Pap smear can pick up these organisms even when they are doing nothing harmful, which often leads to unnecessary worry. Whether the finding matters depends less on the yeast itself and more on whether you have symptoms.

How Common Candida Is on a Pap Smear

In one study reviewing over 10,000 Pap smears, Candida showed up on about 3 percent of them. Of those women, roughly seven out of ten had no symptoms at all. Only about one in five had the classic signs of a yeast infection such as itching, burning, or discharge.² That three-percent figure likely underestimates how many women actually carry Candida, because Pap smears are not particularly good at detecting yeast. When researchers compared Pap smear results to fungal cultures (the gold standard for identifying yeast), the Pap smear caught only about a quarter of the cases that culture identified.³ In that study, culture found Candida in about 30 percent of samples, while the Pap smear flagged it in fewer than 8 percent. Mild and some moderate levels of colonization simply don’t leave enough visible yeast cells or pseudohyphae on the slide for the cytologist to spot them.

So when Candida does appear on your Pap results, it often means the yeast was present in large enough quantities to be visible under the microscope. That can sound alarming, but it says more about what the test happened to catch than about whether something is wrong. A separate study looking at asymptomatic women found that about a third of them had Candida when both Pap smear and culture results were combined, reinforcing the idea that carrying yeast without symptoms is remarkably common.⁴

Why the Pap Smear Reports It at All

The Pap smear was designed to screen for cervical cell abnormalities, not to diagnose infections. But because the cytologist is examining vaginal and cervical cells under high magnification, organisms like Candida, Trichomonas, and certain bacteria are visible and get noted in the report as incidental findings. The report typically lists these under a section called “organisms” or “other findings,” separate from the main assessment of cell abnormalities. Seeing Candida mentioned there is not the same as a clinical diagnosis of a yeast infection. It simply means the lab noticed yeast on the slide.

This distinction matters. A yeast infection is a clinical diagnosis, meaning it depends on symptoms like itching, redness, thick discharge, and irritation, not just on whether yeast is present. Many women carry Candida as a harmless passenger. In healthy women, vaginal yeast colonization is an asymptomatic state, with Candida albicans being the most commonly found species.⁵ The yeast exists in balance with protective bacteria and the local immune environment. Problems arise only when that balance shifts and the yeast overgrows.

When Candida on a Pap Smear Does Not Need Treatment

If you have no symptoms, the standard recommendation is to leave it alone. Clinical guidelines state clearly that a woman with asymptomatic colonization should not be treated, and neither should an asymptomatic sexual partner.⁶ Treating Candida that isn’t causing problems has no proven benefit and can contribute to antifungal resistance over time, making future infections harder to manage. It can also disrupt the vaginal microbial balance that was keeping things stable in the first place.

Occasionally, a provider who sees Candida on a Pap result may prescribe antifungals even without clear symptoms, especially if the patient reports vague discomfort. In the study of over 10,000 Pap smears, the Candida finding directly influenced treatment decisions in about a fifth of cases and confirmed treatment already started in another third.² Whether that treatment was always warranted is debatable. The takeaway is that Candida on a Pap smear can prompt a conversation with your provider, but if you feel fine, treatment is not automatically needed.

When Treatment Is Appropriate

Treatment makes sense when you have symptoms. Classic yeast infection signs include vulvar itching, soreness, redness, and a thick white discharge sometimes described as cottage cheese-like. Burning during urination or sex is also common. If those symptoms line up with Candida on your Pap smear, your provider will usually offer antifungal treatment, either a short course of topical medication like clotrimazole or miconazole, or an oral dose of fluconazole.

If you experience four or more episodes in a single year, that qualifies as recurrent vulvovaginal candidiasis. Managing recurrent infections typically involves longer initial treatment followed by a maintenance regimen. An expert consensus found that topical azoles, along with intravaginal boric acid for tougher cases, are the main tools used. After clearing the acute episode, maintenance dosing usually starts at one to three times per week and then tapers based on how frequently infections return.⁷ Recurrent infections deserve a closer look with your provider, because sometimes a non-albicans species is involved, which responds differently to standard treatment.

What Makes Some Women More Likely to Carry Candida

Several factors shift the odds of vaginal Candida colonization. Estrogen is a major one. It promotes the maturation of vaginal epithelial cells, which produce glycogen, and glycogen is essentially food for Candida.⁸ This explains why yeast colonization tends to be more common during the reproductive years and in women taking estrogen-containing contraceptives. Pregnancy raises estrogen levels even further, and one study of asymptomatic pregnant women found Candida albicans in about one in eight, with the highest rates in women aged 21 to 30.⁹

Diabetes is another well-established risk factor. Elevated blood sugar gives Candida more fuel, and immune function can be altered in people whose blood sugar is not well controlled. Research has found that women with type 1 diabetes were roughly three times as likely to be colonized with Candida compared to those with type 2, even after accounting for differences in blood sugar control.¹⁰ Poor glycemic control, measured by higher hemoglobin A1c levels, had its own independent effect on colonization risk. Broader reviews have confirmed that urogenital Candida infections are increasingly common in people with diabetes, especially when blood sugar management is suboptimal.¹¹

Antibiotics are the third classic trigger. Broad-spectrum antibiotics can reduce or alter the protective Lactobacillus bacteria that normally keep Candida in check. When that microbial restraint weakens, yeast can proliferate and sometimes cause symptoms.¹² This is why yeast infections sometimes follow a course of antibiotics for an unrelated condition like a sinus infection or urinary tract infection. Other risk factors include immunosuppression, use of corticosteroids, and wearing tight or non-breathable undergarments, though these are less studied.

Not All Candida Is the Same Species

When your Pap report says “Candida,” it usually means Candida albicans, which accounts for the majority of vaginal yeast colonization and infections. But non-albicans species exist and can matter. Candida glabrata ranks second or third among Candida species causing vaginal infections, and it poses a particular challenge because it has innate resistance to azole antifungals like fluconazole, the most commonly prescribed treatment.¹³

A study of women with vaginal discharge in Namibia found that while nearly all Candida albicans isolates were susceptible to fluconazole, every single non-albicans isolate tested (including all the Candida glabrata and Candida krusei) was resistant to it.¹⁴ This is clinically important for women who keep getting yeast infections that don’t respond to standard fluconazole. If your infections keep coming back despite treatment, your provider may send a vaginal culture to identify the exact species. Boric acid suppositories and nystatin are among the alternatives that work against non-albicans species.⁷ A Pap smear alone generally cannot tell you which species is present.

Candida on a Pap Smear During Pregnancy

Pregnancy amplifies the conditions that favor Candida colonization: estrogen is high, the immune system is partially suppressed to protect the developing fetus, and glycogen production in vaginal tissue increases. Finding Candida on a prenatal Pap smear is therefore not unusual. The question of whether asymptomatic Candida colonization during pregnancy warrants treatment has been studied in the context of preterm birth risk. A pilot trial explored whether treating asymptomatic vaginal Candida in early pregnancy could reduce preterm delivery. The study used clotrimazole, classified as a Category A drug in pregnancy, meaning it has been widely used without evidence of harm to the fetus.¹⁵ While the idea is biologically plausible, the evidence has not been strong enough to change standard practice. The current approach remains the same as for non-pregnant women: treat symptomatic infections and leave asymptomatic colonization alone unless your provider has a specific reason to intervene.

If you do develop symptoms during pregnancy, topical antifungals like clotrimazole and miconazole are the typical first-line treatments. Oral fluconazole is generally avoided during pregnancy, especially in the first trimester, due to concerns about potential birth defects at higher doses. If your prenatal Pap smear mentions Candida and you have no itching, discharge, or irritation, the yeast is almost certainly just doing what it does in a high-estrogen environment and does not require treatment.

How Candida Can Complicate Pap Smear Interpretation

Beyond the simple question of “should I treat this yeast,” Candida on a Pap smear can create an interpretive wrinkle for the cytologist reading the slide. Yeast and the inflammation it sometimes triggers can cause reactive cellular changes in the cervical cells, meaning the cells look slightly abnormal even though nothing precancerous is happening. These reactive changes can sometimes resemble the cell changes caused by human papillomavirus (HPV), which is what the Pap smear is really designed to detect.

Researchers have investigated how to tell these apart. One study found that a specific feature, called compression in binucleated cells, can help distinguish true HPV-related changes from the reactive changes caused by Candida-related inflammation.¹⁶ In practical terms, this means Candida on a slide can occasionally lead to an ambiguous Pap result that prompts follow-up testing, such as HPV co-testing, which might have been unnecessary if the inflammation from yeast had been recognized. If your Pap comes back with a result like “atypical squamous cells of undetermined significance” and Candida is also noted, your provider may consider the yeast-related inflammation as a possible explanation and recommend a repeat Pap or HPV test rather than jumping straight to more invasive follow-up.

The Shift Toward HPV-Based Screening

Cervical cancer screening is moving away from the traditional Pap smear as the sole test and toward HPV-based primary screening in many countries and healthcare settings. HPV tests look for the DNA or RNA of high-risk HPV strains rather than examining cells under a microscope. One consequence of this shift is that incidental findings like Candida may be reported less often. When the primary screening test is an HPV assay rather than a cytology slide, there is no cytologist looking at cells who might notice yeast. Candida would only get flagged if a reflex Pap is performed after a positive HPV result.

For women accustomed to seeing organism findings on their Pap reports, the switch to HPV-first screening may mean fewer of these incidental Candida detections going forward. Whether that is a loss depends on your perspective. Given that most Candida found on Pap smears is asymptomatic and requires no treatment, detecting it less often probably reduces unnecessary anxiety and unnecessary prescriptions more than it misses anything clinically important.

Managing the Anxiety of an Abnormal-Sounding Result

Even though Candida on a Pap smear is common and usually harmless, seeing anything unexpected on a cervical screening report can trigger real anxiety. Research on how women respond to mildly abnormal cervical screening results found that nearly half of women in one group believed they had cancer after being told their smear was mildly abnormal, even when the abnormality was minor.¹⁷ That study was specifically about cell abnormalities rather than Candida, but it illustrates how screening results can be easily misinterpreted. A finding of “organisms identified: Candida species” on a Pap report sits next to language about cervical cells, and without context, it can feel like something is wrong.

If your report mentions Candida and you have no symptoms, the most constructive step is to ask your provider whether any action is needed. In the vast majority of cases, the answer is no. The yeast was there before the test and will likely continue to be there afterward, coexisting peacefully with the rest of your vaginal microbiome. Treating it without symptoms is a bit like taking antibiotics for bacteria that are supposed to be in your gut. The organism is not the problem; it becomes a problem only when it overgrows past the point your body can manage it comfortably.

The Immune Balancing Act That Keeps Candida in Check

Your vaginal immune system performs a constant balancing act. It needs to tolerate the Candida that naturally lives there without mounting an aggressive inflammatory response, while still being ready to fight back if the yeast starts to overgrow. Research in animal models has shown that this tolerance depends in part on an enzyme called IDO1, which triggers the production of molecules called kynurenines. These molecules help activate regulatory immune cells that produce anti-inflammatory signals and keep the local immune response measured rather than excessive.¹⁸ When this pathway was missing in experimental animals, they lost the ability to control fungal growth and developed more inflammation upon re-infection.

This helps explain why some women can carry Candida for years without ever getting a symptomatic yeast infection, while others seem to get one every few months. Individual differences in this immune tolerance machinery, combined with the risk factors discussed earlier, determine where you land on the spectrum. The presence of Candida on your Pap smear is just one snapshot of that ongoing negotiation between your immune system and the yeast. Most of the time, your body is winning the negotiation without you ever knowing there was one.